Puma Biotechnology | PBYI - Ordinary Share Capital


Puma Biotechnology reported $5K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amgen USD 539M 1000K Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Exelixis USD 268.1M 2.03M Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Moderna USD 391M 2M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024
Vertex Pharmaceuticals USD 254M 0 Dec/2025